Scientists are looking closely at how the body heals after inflammation. In patients with inflammatory bowel disease, certain cells called intestinal subepithelial myofibroblasts (ISEMFs) play a major role. While these cells normally help repair the gut lining and manage immune responses, they can become overactive when exposed to constant inflammation or bacteria. When this happens, they cause the tissue to scar and harden, which is known as fibrosis.
Advanced mapping of these cells shows that they are not all the same. Different types of these cells respond differently to the environment. Some specific groups have been linked to more severe scarring in the gut. This discovery helps researchers understand why some patients experience more permanent tissue damage than others.
Because these cells are central to the healing process, they are being studied as targets for future treatments. However, it is important to note that this research is currently focused on biological mechanisms. No specific new drugs or clinical trials were reported in this review. These findings provide a foundation for developing better ways to manage long-term damage in inflammatory bowel disease.
